Aspirin for Primary Prevention in Adults Older than 70 Years is Not Supported by High-Quality Trial Data and May Cause Harm

We read with interest the commentary on aspirin in primary prevention by Gitin et al.1 As ASPirin in Reducing Events in the Elderly (ASPREE) investigators, 1 of 3 key aspirin primary prevention trials referenced in this paper, we write to reiterate the unambiguous message from the ASPREE trial.2

About admin

Now Dr. Jack Straw is in charge of the website, and organizes it so that medical care is available to everyone. In addition, he is an active member of the medical community, regularly attending international conferences and sharing his experience and knowledge. Dr. Straw is not only a medical professional and website manager, but also a loving husband and father of his beautiful children.
View all posts by admin →

Leave a Reply

Your email address will not be published. Required fields are marked *